Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Expression and Role of Methylenetetrahydrofolate Dehydrogenase 1 Like (MTHFD1L) in Bladder CancerTranslational Oncology.  12:1416-1424. 2019
2019 Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinomaModern Pathology.  32:1544-1550. 2019
2019 Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladderVirchows Archiv.  475:349-356. 2019
2019 PD-L1 expression in non–small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory-developed test using clone E1L3N in comparison with 22C3 and SP263 assaysHuman Pathology.  90:54-59. 2019
2019 Tumor immune microenvironment in non–muscle-invasive urothelial carcinoma of the bladderHuman Pathology.  89:24-32. 2019
2019 Clinical implication of the mammalian target of rapamycin pathway in upper tract urothelial carcinoma with negative GATA binding protein 3 expressionInternational Journal of Urology.  26:678-679. 2019
2019 Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinomaCancer Science.  110:1771-1779. 2019
2019 INSL3 Expression in Leydig Cell Hyperplasia and Leydig Cell TumorsApplied Immunohistochemistry and Molecular Morphology.  27:203-209. 2019
2019 Rare case of squamous cell carcinoma arising from tunica vaginalis in a background of chronic hydroceleUrology Case Reports.  23:55-57. 2019
2019 Re: Assessing cancer progression and stable disease after neoadjuvant chemotherapy for organ-confined muscle-invasive bladder cancerJournal of Urology, The.  201:441. 2019
2019 Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutationsHuman Pathology.  85:1-9. 2019
2019 p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid TumorsCancer Cell.  35:204-220.e9. 2019
2019 Expression of programmed cell death ligand 1 in non–small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 assayCancer Cytopathology.  127:52-61. 2019
2019 Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinomaVirchows Archiv.  474:21-27. 2019
2019 Characterization of glycine-N-acyltransferase like 1 (GLYATL1) in prostate cancerProstate.  79:1629-1639. 2019
2019 Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytologyVirchows Archiv2019
2019 Prostate cancer, version 2.2019Journal of the National Comprehensive Cancer Network.  17:479-505. 2019
2018 Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: Evaluation of small biopsies reliability (Oncotarget (2017) 8 (90123-90131) DOI: 10.18632/oncotarget.21485)Oncotarget.  9:37077. 2018
2018 Wnt receptor Frizzled 8 is a target of ERG in prostate cancerProstate.  78:1311-1320. 2018
2018 A modified clinicopathological tumor staging system for survival prediction of patients with penile cancer ChiCTR16008041 ChiCTR 11 Medical and Health Sciences 1112 Oncology and CarcinogenesisCancer Communications.  38. 2018
2018 Erratum: Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy (eLife (2018) 7 PII: e43237)eLife.  7. 2018
2018 Genito-urinary genomics and emerging biomarkers for immunomodulatory cancer treatmentSeminars in Cancer Biology.  52:216-227. 2018
2018 PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant CutoffsAmerican Journal of Surgical Pathology.  42:1384-1389. 2018
2018 Hypomethylation, endogenous retrovirus expression, and interferon signaling in testicular germ cell tumorsProceedings of the National Academy of Sciences.  115:E8580-E8582. 2018
2018 A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer ProgressionNeoplasia : An International Journal for Oncology Research.  20:894-904. 2018
2018 Eosinophilic solid and cystic (ESC) renal cell carcinomas harbor tsc mutations: Molecular analysis supports an expanding clinicopathologic spectrumAmerican Journal of Surgical Pathology.  42:1166-1181. 2018
2018 High-fat diet-induced inflammation accelerates prostate cancer growth via IL6 signalingClinical Cancer Research.  24:4309-4318. 2018
2018 PD-L1 Expression Heterogeneity in Non–Small Cell Lung Cancer: Defining Criteria for Harmonization between Biopsy Specimens and Whole SectionsJournal of Thoracic Oncology.  13:1113-1120. 2018
2018 Iatrogenic pathology of the urinary bladderSeminars in Diagnostic Pathology.  35:218-227. 2018
2018 PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263Oncotarget.  9:30465-30471. 2018
2018 Single 15-Min Protocol Yields the Same Cryoablation Size and Margin as the Conventional 10–8–10-Min Protocol: Results of Kidney and Liver Swine ExperimentCardioVascular and Interventional Radiology.  41:1089-1094. 2018
2018 miR-34a regulates expression of the stathmin-1 oncoprotein and prostate cancer progressionCell Growth and Differentiation.  16:1125-1137. 2018
2018 Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate CancerAmerican Journal of Pathology.  188:1478-1485. 2018
2018 Nuclear factor-kb promotes urothelial tumorigenesis and cancer progression via cooperation with androgen receptor signalingMolecular Cancer Therapeutics.  17:1303-1314. 2018
2018 Reduced immunohistochemical PTEN staining is associated with higher progression rate and recurrence episodes in non-invasive low-grade papillary urothelial carcinoma of the bladderVirchows Archiv.  472:969-974. 2018
2018 Prognostic impact of concomitant loss of PBRM1 and BAP1 protein expression in early stages of clear cell renal cell carcinomaUrologic Oncology: Seminars and Original Investigations.  36:243.e1-243.e8. 2018
2018 Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidyeLife.  7. 2018
2018 Re-evaluation of 33 ‘unclassified’ eosinophilic renal cell carcinomas in young patientsHistopathology.  72:588-600. 2018
2018 ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signalingEndocrine Connections.  7:1397-1408. 2018
2018 Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expressionBritish Journal of Cancer.  118:213-223. 2018
2018 YAP1 and COX2 coordinately regulate urothelial cancer stem-like cellsCancer Research.  78:168-181. 2018
2017 AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic disseminationNature Communications.  8. 2017
2017 Prostate Cancer: An Update on Molecular Pathology with Clinical ImplicationsEuropean Urology Supplements.  16:253-271. 2017
2017 Spectrum of genetic mutations in de novo PUNLMP of the urinary bladderVirchows Archiv.  471:761-767. 2017
2017 Pathology Imagebase—a reference image database for standardization of pathologyHistopathology.  71:677-685. 2017
2017 MicroRNAs, promising biomarkers in the diagnosis of Xp11 translocation RCC—replyHuman Pathology.  68:206-207. 2017
2017 MicroRNA expression profiling of Xp11 renal cell carcinomaHuman Pathology.  67:18-29. 2017
2017 Analytic, preanalytic, and clinical validation of p53 IHC for detection of TP53 missense mutation in prostate cancerClinical Cancer Research.  23:4693-4703. 2017
2017 Preparing pathology for the molecular eraVirchows Archiv.  471:137-140. 2017
2017 Toward personalized management in bladder cancer: the promise of novel molecular taxonomyVirchows Archiv.  471:271-280. 2017
2017 Intravesical BCG Induces CD4+ T-cell expansion in an immune competent model of bladder cancerCancer Immunology Research.  5:594-603. 2017
2017 A phase II trial of dovitinib in BCG-unresponsive urothelial carcinoma with FGFR3 mutations or overexpression: Hoosier Cancer Research Network trial HCRN 12-157Clinical Cancer Research.  23:3003-3011. 2017
2017 GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticatorHuman Pathology.  64:83-90. 2017
2017 Strong association of insulin-like growth factor 1 receptor expression with histologic grade, subtype, and HPV status in penile squamous cell carcinomas: a tissue microarray study of 112 casesVirchows Archiv.  470:695-701. 2017
2017 Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher AssayJournal of Molecular Diagnostics.  19:475-484. 2017
2017 Assessing Cancer Progression and Stable Disease After Neoadjuvant Chemotherapy for Organ-confined Muscle-invasive Bladder CancerUrology.  102:148-158. 2017
2017 Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancerOncotarget.  8:91199-91208. 2017
2017 Immune-checkpoint status in penile squamous cell carcinoma: a North American cohortHuman Pathology.  59:55-61. 2017
2017 Lymph node density predicts recurrence and death after inguinal lymph node dissection for penile cancerInvestigative and Clinical Urology.  58:20-25. 2017
2017 PD-L1 expression heterogeneity in non-small cell lung cancer: Evaluation of small biopsies reliabilityOncotarget.  8:90123-90131. 2017
2017 Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?Urologic Oncology: Seminars and Original Investigations.  35:34.e17-34.e25. 2017
2017 Urological cancer related to familial syndromesInternational Brazilian Journal of Urology.  43:192-201. 2017
2016 Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tractCancer Biology and Therapy.  17:1188-1196. 2016
2016 SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy CohortJournal of Urology, The.  196:1436-1444. 2016
2016 Circulating Tumor DNA as a Marker of Therapeutic Response in Patients With Renal Cell Carcinoma: A Pilot StudyClinical Genitourinary Cancer.  14:e515-e520. 2016
2016 Clinical mutational profiling of bone metastases of lung and colon carcinoma and malignant melanoma using next-generation sequencingCancer Cytopathology.  124:744-753. 2016
2016 High prevalence of TERT promoter mutations in micropapillary urothelial carcinomaVirchows Archiv.  469:427-434. 2016
2016 TFEB-amplified renal cell carcinomasAmerican Journal of Surgical Pathology.  40:1484-1495. 2016
2016 Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ systemCA: A Cancer Journal for Clinicians.  66:408-436. 2016
2016 For staining of ALK protein, the novel D5F3 antibody demonstrates superior overall performance in terms of intensity and extent of staining in comparison to the currently used ALK1 antibodyVirchows Archiv.  469:345-350. 2016
2016 Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologistsHistopathology.  69:441-449. 2016
2016 The intratumoral balance between metabolic and immunologic gene expression is associated with anti-PD-1 response in patients with renal cell carcinomaCancer Immunology Research.  4:726-733. 2016
2016 Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical CystectomyAnnals of Surgical Oncology.  23:2715-2722. 2016
2016 High-resolution telomere fluorescence in situ hybridization reveals intriguing anomalies in germ cell tumorsHuman Pathology.  54:106-112. 2016
2016 The utility of STAT6 and ALDH1 expression in the differential diagnosis of solitary fibrous tumor versus prostate-specific stromal neoplasmsHuman Pathology.  54:184-188. 2016
2016 ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasionOncotarget.  7:53599-53610. 2016
2016 Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladderHuman Pathology.  53:8-13. 2016
2016 Extent of renal vein invasion influences prognosis in patients with renal cell carcinomaBJU International.  118:112-117. 2016
2016 Overexpression of Insulin-like Growth Factor-1 Receptor Is Associated with Penile Cancer ProgressionUrology.  92:51-56. 2016
2016 Role for anti-PD-L1 immune checkpoint inhibitor in advanced urothelial carcinomaLancet.  387:1881-1882. 2016
2016 The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladderOncoImmunology.  5. 2016
2016 High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladderModern Pathology.  29:511-515. 2016
2016 Test feasibility of next-generation sequencing assays in clinical mutation detection of small biopsy and fine needle aspiration specimensAmerican Journal of Clinical Pathology.  145:696-702. 2016
2016 A Retrospective Analysis of the Effect on Survival of Time from Diagnosis to Neoadjuvant Chemotherapy to Cystectomy for Muscle Invasive Bladder CancerJournal of Urology, The.  195:880-885. 2016
2016 A right atrial mass: "more than meets the eye"Journal of Clinical Oncology.  34:e49-e50. 2016
2016 Cyclosporine A and tacrolimus inhibit urothelial tumorigenesisMolecular Carcinogenesis.  55:161-169. 2016
2016 Emerging Bladder Cancer Biomarkers and Targets of TherapyUrologic Clinics of North America.  43:63-76. 2016
2016 Germline variants in asporin vary by race, modulate the tumor microenvironment, and are differentially associated with metastatic prostate cancerClinical Cancer Research.  22:448-458. 2016
2016 Clinical validation of the 2005 isup gleason grading system in a cohort of intermediate and high risk men undergoing radical prostatectomyPLoS ONE.  11. 2016
2016 Frequent BRAF V600E mutations in metanephric stromal tumorAmerican Journal of Surgical Pathology.  40:719-722. 2016
2016 Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary MalignanciesPLoS ONE.  11. 2016
2016 Molecular Diagnostics for Precision Medicine in Colorectal Cancer: Current Status and Future PerspectiveBioMed Research International.  2016. 2016
2016 Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladderHuman Pathology.  47:20-25. 2016
2016 TFE3-fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancersAmerican Journal of Surgical Pathology.  40:723-737. 2016
2016 Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk MenEuropean Urology.  69:157-165. 2016
2015 Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic AdenocarcinomasClinical Cancer Research.  21:5619-5629. 2015
2015 Renal carcinoma associated with a novel succinate dehydrogenase A mutation: A case report and review of literature of a rare subtype of renal carcinomaHuman Pathology.  46:1951-1955. 2015
2015 Erratum: Identification and validation of protein biomarkers of response to neoadjuvant platinum chemotherapy in muscle invasive urothelial carcinoma (PLoS ONE (2015) 10:7 (e0131245) (DOI:10.1371/journal.pone.0131245))PLoS ONE.  10. 2015
2015 Androgen-regulated SPARCL1 in the tumor microenvironment inhibits metastatic progressionCancer Research.  75:4322-4334. 2015
2015 PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomasProstate.  75:1610-1619. 2015
2015 Identification and validation of Protein biomarkers of response to neoadjuvant platinum chemotherapy in muscle invasive urothelial carcinomaPLoS ONE.  10. 2015
2015 18F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancerJournal of Nuclear Medicine.  56:1003-1010. 2015
2015 Smooth muscle and adenoma-like renal tumor: A previously unreported variant of mixed epithelial stromal tumor or a distinctive renal neoplasm?Human Pathology.  46:894-905. 2015
2015 Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomesUrologic Oncology: Seminars and Original Investigations.  33:204.e1-204.e7. 2015
2015 Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: A tissue microarray study of 112 casesHuman Pathology.  46:761-766. 2015
2015 Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinomaUrology.  85:703.e1-703.e6. 2015
2015 Cyclin A1 expression predicts progression in pT1 urothelial carcinoma of bladder: A tissue microarray study of 149 patients treated by transurethral resectionHistopathology.  66:262-269. 2015
2015 Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1Oncotarget.  6:1582-1593. 2015
2015 ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progressionOncotarget.  6:29860-29876. 2015
2015 Grade Heterogeneity in Small Renal Masses: Potential Implications for Renal Mass BiopsyJournal of Urology, The.  193:36-40. 2015
2015 Human papillomavirus infection and immunohistochemical p16INK4a expression as predictors of outcome in penile squamous cell carcinomasHuman Pathology.  46:532-540. 2015
2015 Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical useCancer Prevention Research.  8:208-221. 2015
2015 Molecular Updates in Prostate CancerSurgical Pathology Clinics.  8:561-580. 2015
2015 Primary renal sclerosing epithelioid fibrosarcoma: Report of 2 cases with EWSR1-CREB3L1 gene fusionAmerican Journal of Surgical Pathology.  39:365-373. 2015
2015 Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: A systematic review and meta-analysisOncotarget.  6:39088-39097. 2015
2015 Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancerModern Pathology.  28:612-630. 2015
2015 Utility of uroplakin II expression as a marker of urothelial carcinomaHuman Pathology.  46:58-64. 2015
2014 GSTP1 promoter methylation is associated with recurrence in early stage prostate cancerJournal of Urology, The.  192:1542-1548. 2014
2014 Preliminary evaluation of urinary soluble Met as a Biomarker for urothelial carcinoma of the bladderJournal of Translational Medicine.  12. 2014
2014 Pathological characteristics and radiographic correlates of complex renal cystsUrologic Oncology: Seminars and Original Investigations.  32:1010-1016. 2014
2014 High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other originsJournal of Hematology & Oncology.  7. 2014
2014 Rb loss is characteristic of prostatic small cell neuroendocrine carcinomaClinical Cancer Research.  20:890-903. 2014
2014 Detection of circulating tumor DNA in early- and late-stage human malignanciesScience Translational Medicine.  6. 2014
2014 Combining routine morphology, p16INK4a immunohistochemistry, and in situ hybridization for the detection of human papillomavirus infection in penile carcinomas: A tissue microarray study using classifier performance analysesUrologic Oncology: Seminars and Original Investigations.  32:171-177. 2014
2014 Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasmsHuman Pathology.  45:244-248. 2014
2014 A comprehensive resequence-analysis of 250 kb region of 8q24.21 in men of African ancestryProstate.  74:579-589. 2014
2014 An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urineOncotarget.  5:5218-5233. 2014
2014 Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository networkProstate.  74:61-69. 2014
2014 Clear cell papillary renal cell carcinoma: Micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinomaHuman Pathology.  45:1130-1138. 2014
2014 Clinical heterogeneity of Xp11 translocation renal cell carcinoma: Impact of fusion subtype, age, and stageModern Pathology.  27:875-886. 2014
2014 Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urineOncotarget.  5:3350-3361. 2014
2014 Estrogen receptor alpha prevents bladder cancer development via INPP4B inhibited Akt pathway in vitro and in vivoOncotarget.  5:7917-7935. 2014
2014 Expression of UDP-glucuronosyltransferase 1A in bladder cancer: Association with prognosis and regulation by estrogenMolecular Carcinogenesis.  53:314-324. 2014
2014 GATA3 expression in small cell carcinoma of bladder and prostate and its potential role in determining primary tumor originHuman Pathology.  45:1682-1687. 2014
2014 High prevalence of screen detected prostate cancer in West Africans: Implications for racial disparity of prostate cancerJournal of Urology, The.  192:730-736. 2014
2014 Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: A tissue microarray study of 112 casesHistopathology.  64:863-871. 2014
2014 Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: A retrospective study of patients treated using radical cystectomyUrology.  83:1444.e1-1444.e6. 2014
2014 Long interspersed element-1 protein expression is a hallmark of many human cancersAmerican Journal of Pathology.  184:1280-1286. 2014
2014 Pharmacokinetics and toxicology of a fibroblast activation protein (FAP)-Activated prodrug in murine xenograft models of human cancerProstate.  74:1308-1319. 2014
2014 Reduced glucocorticoid receptor expression predicts bladder tumor recurrence and progressionAmerican Journal of Clinical Pathology.  142:157-164. 2014
2014 Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendationsAnnales de Pathologie.  34:448-461. 2014
2014 Sacrococcygeal teratomas: Clinico-pathological characteristics and isochromosome 12p statusModern Pathology.  27:562-568. 2014
2014 T(6;11) Renal cell carcinoma (RCC): Expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed casesAmerican Journal of Surgical Pathology.  38:604-614. 2014
2014 The utility of an extensive postchemotherapy staging evaluation in patients receiving neoadjuvant chemotherapy for bladder cancerUrology.  84:358-364. 2014
2014 VCL-ALK renal cell carcinoma in children with sickle-cell trait: The eighth sickle-cell nephropathy?American Journal of Surgical Pathology.  38:858-863. 2014
2013 TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urineCancer Research.  73:7162-7167. 2013
2013 Chromophobe renal cell carcinoma: Multiphase MDCT enhancement patterns and morphologic featuresAmerican Journal of Roentgenology.  201:1268-1276. 2013
2013 Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinomaHuman Pathology.  44:2668-2676. 2013
2013 Frequent truncating mutations of STAG2 in bladder cancerNature Genetics.  45:1428-1430. 2013
2013 Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethraHuman Pathology.  44:2760-2767. 2013
2013 The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: A tissue microarray and digital image analysis study of 112 casesHuman Pathology.  44:2690-2695. 2013
2013 The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomasHuman Pathology.  44:2651-2657. 2013
2013 Combined treatment effects of radiation and immunotherapy: Studies in an autochthonous prostate cancer modelInternational Journal of Radiation Oncology - Biology - Physics.  87:769-776. 2013
2013 Activation of mammalian target of rapamycin signaling pathway markers in minute adenocarcinoma of the prostateUrology.  82:1083-1089. 2013
2013 Molecular genetics and genomics progress in urothelial bladder cancerSeminars in Diagnostic Pathology.  30:313-320. 2013
2013 Performance models of infiltration within the sub-basin of the river Marcela, on the upper Rio Grande-MGSemina : Ciências Agrárias.  34:2589-2602. 2013
2013 Dysregulation of the mammalian target of rapamycin pathway in chromophobe renal cell carcinomasHuman Pathology.  44:2323-2330. 2013
2013 Renal cell carcinoma presenting with brain metastasis from a 1.6 cm primary tumorCanadian Journal of Urology.  20:6965-6967. 2013
2013 Relevance of the mammalian target of rapamycin pathway in the prognosis of patients with high-risk non-muscle invasive bladder cancerHuman Pathology.  44:1766-1772. 2013
2013 Comparison of biochemical recurrence-free survival between periprostatic and pelvic lymph node metastases of prostate cancerInternational Journal of Surgical Pathology.  21:352-357. 2013
2013 Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinomaWorld Journal of Urology.  31:861-867. 2013
2013 Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation serviceAmerican Journal of Surgical Pathology.  37:1150-1163. 2013
2013 Focal positive prostate-specific membrane antigen (PSMA) expression in ganglionic tissues associated with prostate neurovascular bundle: Implications for novel intraoperative PSMA-based fluorescent imaging techniquesUrologic Oncology: Seminars and Original Investigations.  31:572-575. 2013
2013 Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumorsHuman Pathology.  44:1293-1299. 2013
2013 Determination of the nonlethal margin inside the visible "ice-ball" during percutaneous cryoablation of renal tissueCardioVascular and Interventional Radiology.  36:783-790. 2013
2013 Clinical applications of recent molecular advances in urologic malignancies: No longer chasing a "mirage"?Advances in Anatomic Pathology.  20:175-203. 2013
2013 Intrapancreatic accessory spleen: A case report and review of literatureDiagnostic Cytopathology.  41:466-469. 2013
2013 TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewalProceedings of the National Academy of Sciences.  110:6021-6026. 2013
2013 Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancerJournal of Translational Medicine.  11. 2013
2013 Dysregulation of mammalian target of rapamycin pathway in plasmacytoid variant of urothelial carcinoma of the urinary bladderHuman Pathology.  44:612-622. 2013
2013 Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinomaCell Cycle.  12:1058-1070. 2013
2013 A broad survey of cathepsin k immunoreactivity in human neoplasmsAmerican Journal of Clinical Pathology.  139:151-159. 2013
2013 LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinomaExperimental and Molecular Pathology.  94:29-32. 2013
2013 Handling and staging of renal cell carcinoma: The International Society of Urological Pathology Consensus (ISUP) conference recommendationsAmerican Journal of Surgical Pathology.  37:1505-1517. 2013
2013 High levels of phosphatase and tensin homolog expression are associated with tumor progression, tumor recurrence, and systemic metastases in pt1 urothelial carcinoma of the bladder: A tissue microarray study of 156 patients treated by transurethral resectionUrology.  81:116-122. 2013
2013 Renal tumors: Diagnostic and prognostic biomarkersAmerican Journal of Surgical Pathology.  37:1518-1531. 2013
2013 The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasiaAmerican Journal of Surgical Pathology.  37:1469-1489. 2013
2013 The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parametersAmerican Journal of Surgical Pathology.  37:1490-1504. 2013
2012 Immunoexpression status and prognostic value of mammalian target of rapamycin and hypoxia-induced pathway members in papillary cell renal cell carcinomasHuman Pathology.  43:2129-2137. 2012
2012 Mechanism of growth inhibition of prostate cancer xenografts by valproic acidJournal of Biomedicine and Biotechnology.  2012. 2012
2012 Molecular Pathology of Bladder CancerSurgical Pathology Clinics.  5:843-858. 2012
2012 Tissue expression of CD10 protein in colorectal carcinoma: Correlation with the anatomopathological features of the tumor and with lymph node and liver metastasesJournal of Coloproctology.  32:34-39. 2012
2012 GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumorHuman Pathology.  43:2033-2040. 2012
2012 Immunohistochemical expression of minichromosome maintenance complex protein 2 predicts biochemical recurrence in prostate cancer: A tissue microarray and digital imaging analysis-based study of 428 casesHuman Pathology.  43:1852-1865. 2012
2012 Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancerModern Pathology.  25:1543-1549. 2012
2012 High epidermal growth factor receptor immunohistochemical expression in urothelial carcinoma of the bladder is not associated with EGFR mutations in exons 19 and 21: A study using formalin-fixed, paraffin-embedded archival tissuesHuman Pathology.  43:1590-1595. 2012
2012 Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrumAmerican Journal of Surgical Pathology.  36:1516-1526. 2012
2012 A 66-year-old man with prostate-specific antigen recurrence and lung mass after radical prostatectomyUrology.  80:247-249. 2012
2012 Distribution and characterization of subtypes of penile intraepithelial neoplasia and their association with invasive carcinomas: A pathological study of 139 lesions in 121 patientsHuman Pathology.  43:1020-1027. 2012
2012 Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladderUrologic Oncology: Seminars and Original Investigations.  30:428-433. 2012
2012 Thyroid transcription factor 1 expression in a case of renal collecting duct carcinoma - ReplyHuman Pathology.  43:1154. 2012
2012 Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladderBJU International.  109:1716-1726. 2012
2012 Prevalence of BPH and lower urinary tract symptoms in West AfricansProstate Cancer and Prostatic Diseases.  15:170-176. 2012
2012 Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas: Further evidence for a biological distinctionAmerican Journal of Surgical Pathology.  36:783-784. 2012
2012 Results of live donor liver transplantation in patients with hepatitic C virus infection: The HCV 3 trial experienceClinical Transplantation.  26:502-509. 2012
2012 Anti-tumor effects of endogenous prostate cancer-specific CD8 T cells in a murine TCR transgenic modelProstate.  72:514-522. 2012
2012 Emerging critical role of molecular testing in diagnostic genitourinary pathologyArchives of Pathology and Laboratory Medicine.  136:372-390. 2012
2012 High-grade prostatic adenocarcinoma present in a single biopsy core is associated with increased extraprostatic extension, seminal vesicle invasion, and positive surgical margins at prostatectomyUrology.  79:863-868. 2012
2012 Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escapeCancer Research.  72:917-927. 2012
2012 Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: A comparative histopathologic study from a single academic centerHuman Pathology.  43:254-260. 2012
2012 DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminomaBritish Journal of Cancer.  106:414-423. 2012
2012 High-grade papillary urothelial carcinoma of the urinary tract: A clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic centerHuman Pathology.  43:115-120. 2012
2012 Immunohistochemical evidence of dysregulation of the mammalian target of rapamycin pathway in primary and metastatic pheochromocytomasUrology.  80:736.e7-736.e12. 2012
2012 Molecular biomarkers in urothelial carcinoma of the bladder: Are we there yet?Nature Clinical Practice Urology.  9:41-51. 2012
2011 A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis CLiver Transplantation and Surgery.  17:1394-1403. 2011
2011 Erratum: Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy (Cancer (2010) 116 (5517-26))Cancer.  117:5021. 2011
2011 Hepatocyte nuclear factor-1β expression in clear cell adenocarcinomas of the bladder and urethra: Diagnostic utility and implications for histogenesisHuman Pathology.  42:1613-1619. 2011
2011 Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomasModern Pathology.  24:1511-1520. 2011
2011 PTEN protein loss by immunostaining: Analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patientsClinical Cancer Research.  17:6563-6573. 2011
2011 Humanizing π-class glutathione s-transferase regulation in a mouse model alters liver toxicity in response to acetaminophen overdosePLoS ONE.  6. 2011
2011 Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusionsModern Pathology.  24:1313-1319. 2011
2011 Immunoexpression status and prognostic value of mtor and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomasAmerican Journal of Surgical Pathology.  35:1549-1556. 2011
2011 Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypesAmerican Journal of Pathology.  179:1608-1615. 2011
2011 Diffuse expression of PAX2 and PAX8 in the cystic epithelium of mixed epithelial stromal tumor, angiomyolipoma with epithelial cysts, and primary renal synovial sarcoma: Evidence supporting renal tubular differentiationAmerican Journal of Surgical Pathology.  35:1264-1273. 2011
2011 Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findingsInternational Brazilian Journal of Urology.  37:668-669. 2011
2011 Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? correlation with radical prostatectomy findingsAmerican Journal of Surgical Pathology.  35:1351-1355. 2011
2011 Adrenal lymphangioma: Clinicopathologic and immunohistochemical characteristics of a rare lesionHuman Pathology.  42:1013-1018. 2011
2011 High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, AfricaAmerican Journal of Hematology.  86:554-558. 2011
2011 Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomasAmerican Journal of Surgical Pathology.  35:1014-1020. 2011
2011 An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancerCancer Research.  71:3812-3821. 2011
2011 ERG gene rearrangements are common in prostatic small cell carcinomasModern Pathology.  24:820-828. 2011
2011 Genome-wide analysis of genetic alterations in testicular primary seminoma using high resolution single nucleotide polymorphism arraysGenomics.  97:341-349. 2011
2011 Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: An analysis using propensity score matchingBJU International.  107:1956-1962. 2011
2011 Diagnostic use of PAX8, CAIX, TTF-1, and TGB in metastatic renal cell carcinoma of the thyroidAmerican Journal of Surgical Pathology.  35:757-761. 2011
2011 Interobserver variability in histologic evaluation of radical prostatectomy between central and local pathologists: Findings of TAX 3501 multinational clinical trialUrology.  77:1155-1160. 2011
2011 Molecular diagnostics in urologic malignancies a work in progressArchives of Pathology and Laboratory Medicine.  135:610-621. 2011
2011 PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cellcarcinoma to the central nervous systemAmerican Journal of Surgical Pathology.  35:262-267. 2011
2011 Does valproic acid induce neuroendocrine differentiation in prostate cancer?Journal of Biomedicine and Biotechnology.  2011. 2011
2011 Distinctive immunohistochemical profile of penile intraepithelial lesions: A study of 74 casesAmerican Journal of Surgical Pathology.  35:553-562. 2011
2011 Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancersOncotarget.  2:627-637. 2011
2011 Immunohistochemical analysis of SMARCB1/INI-1 expression in collecting duct carcinomaUrology.  78:474.e1-474.e5. 2011
2011 Tumor volume threshold of insignificant prostate cancer-was Dr. Stamey Right all along?Journal of Urology, The.  185:10-11. 2011
2010 Decreased expression of Cyr61 is associated with prostate cancer recurrence after surgical treatmentClinical Cancer Research.  16:5908-5913. 2010
2010 Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomyCancer.  116:5517-5526. 2010
2010 A distinctive subset of PEComas harbors TFE3 gene fusionsAmerican Journal of Surgical Pathology.  34:1395-1406. 2010
2010 Prostate melanosis associated with acinar adenocarcinomaInternational Journal of Surgical Pathology.  18:379-380. 2010
2010 TMPRSS2-ERG fusion as a marker of prostatic lineage in small-cell carcinomaHistopathology.  57:633. 2010
2010 Xp11 translocation renal cell carcinoma (RCC): Extended immunohistochemical profile emphasizing novel RCC markersAmerican Journal of Surgical Pathology.  34:1295-1303. 2010
2010 Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangementsNature Genetics.  42:668-675. 2010
2010 Low-grade papillary urothelial carcinoma of the urinary bladder: A clinicopathologic analysis of a post-world Health Organization/International Society of Urological Pathology classification cohort from a single academic centerArchives of Pathology and Laboratory Medicine.  134:1160-1163. 2010
2010 Low-grade papillary urothelial carcinoma of the urinary bladder: A clinicopathologic analysis of a post-world health organization/international society of urological pathology classification cohort from a single academic centerInternational Brazilian Journal of Urology.  36:506-507. 2010
2010 PAX8 (+)/p63 (-) Immunostaining pattern in renal collecting duct carcinoma (CDC): A useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tractAmerican Journal of Surgical Pathology.  34:965-969. 2010
2010 Renal medullary carcinoma: Molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapyBJU International.  106:62-65. 2010
2010 A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancerClinical Cancer Research.  16:3057-3066. 2010
2010 Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: Evidence from a xenograft studyMolecular Cancer Therapeutics.  9:1525-1535. 2010
2010 Conventional prostatic adenocarcinoma arising in a multilocular prostatic cystadenomaPathology International.  60:413-416. 2010
2010 Extracellular Matrix Associated Protein CYR61 is Linked to Prostate Cancer DevelopmentJournal of Urology, The.  183:1604-1610. 2010
2010 The Relationship of Vascular Endothelial Growth Factor and Coagulation Factor (Fibrin and Fibrinogen) Expression in Clear Cell Renal Cell CarcinomaUrology.  75:608-614. 2010
2010 Erratum: Non-invasive papillary urothelial neoplasms: The 2004 WHO/ISUP classification system (Pathology International (2010) 60:1 (18))Pathology International.  60:147. 2010
2010 Non-invasive papillary urothelial neoplasms: The 2004 WHO/ISUP classification systemPathology International.  60:1-8. 2010
2010 Theranostic and prognostic biomarkers: Genomic applications in urological malignanciesPathology.  42:384-394. 2010
2009 Identification of nuclear structural protein alterations associated with seminomasJournal of Cellular Biochemistry.  108:1274-1279. 2009
2009 TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinomaModern Pathology.  22:1415-1422. 2009
2009 TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomasModern Pathology.  22:1399-1400. 2009
2009 PSMA expression in Schwannoma: A potential clinical mimicker of metastatic prostate carcinomaUrologic Oncology: Seminars and Original Investigations.  27:525-528. 2009
2009 Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomasModern Pathology.  22:1016-1022. 2009
2009 Topoisomerase II α Status in Renal Medullary Carcinoma: Immuno-Expression and Gene Copy Alterations of a Potential Target of TherapyJournal of Urology, The.  182:735-740. 2009
2009 Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidneyAmerican Journal of Surgical Pathology.  33:1103-1106. 2009
2009 Specific detection of prostate cancer cells in urine by multiplex immunofluorescence cytologyHuman Pathology.  40:924-933. 2009
2009 Cyclophosphamide augments antitumor immunity: Studies in an autochthonous prostate cancer modelCancer Research.  69:4309-4318. 2009
2009 Phosphorylated H2AX in Noninvasive Low Grade Urothelial Carcinoma of the Bladder: Correlation With Tumor RecurrenceJournal of Urology, The.  181:1387-1392. 2009
2009 TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomasModern Pathology.  22:359-365. 2009
2009 Editorial CommentUrology.  74:1161-1162. 2009
2009 Editorial CommentJournal of Urology, The.  181:1074-1075. 2009
2009 Multi-institutional validation of the predictive value of ki-67 labeling index in patients with urinary bladder cancerJNCI: Journal of the National Cancer Institute.  101:114-119. 2009
2009 p53 Predictive Value for pT1-2 N0 Disease at Radical CystectomyJournal of Urology, The.  182:907-913. 2009
2008 Benign Mimickers of Prostate Adenocarcinoma on Needle Biopsy and Transurethral ResectionSurgical Pathology Clinics.  1:1-41. 2008
2008 Mesenchymal Tumors of the ProstateSurgical Pathology Clinics.  1:105-128. 2008
2008 Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumorsModern Pathology.  21:1337-1344. 2008
2008 Papillary renal cell carcinoma with low-grade spindle cell foci: A mimic of mucinous tubular and spindle cell carcinomaAmerican Journal of Surgical Pathology.  32:1353-1359. 2008
2008 Profiling the expression pattern of GPI transamidase complex subunits in human cancerModern Pathology.  21:979-991. 2008
2008 Aggressive recurrent respiratory papillomatosis in a neonateInternational Journal of Pediatric Otorhinolaryngology.  72:917-920. 2008
2008 Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissuesProstate.  68:766-772. 2008
2008 Prostatic adenocarcinoma in colorectal biopsy: clinical and pathologic featuresHuman Pathology.  39:543-549. 2008
2008 Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: Report of 21 casesAmerican Journal of Surgical Pathology.  32:461-467. 2008
2008 Fat-predominant mixed epithelial stromal tumor (MEST): Report of a unique case mimicking angiomyolipomaInternational Journal of Surgical Pathology.  16:73-77. 2008
2007 Colorectal adenocarcinoma involving the prostate: report of 9 casesHuman Pathology.  38:1836-1841. 2007
2007 Corticosteroid-free immunosuppression with daclizumab in HCV+ liver transplant recipients: 1-year interim results of the HCV-3 studyLiver Transplantation and Surgery.  13:1521-1531. 2007
2007 LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systemsJournal of Clinical Investigation.  117:3383-3392. 2007
2007 Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancerCancer Research.  67:6136-6145. 2007
2007 Timing of return to normal activities after orbital floor fracture repairPlastic and Reconstructive Surgery.  120:245-251. 2007
2007 Early Prostate Cancer Antigen Expression in Predicting Presence of Prostate Cancer in Men With Histologically Negative BiopsiesJournal of Urology, The.  177:1736-1740. 2007
2007 Distinguishing prostatic from colorectal adenocarcinoma on biopsy samples: The role of morphology and immunohistochemistryArchives of Pathology and Laboratory Medicine.  131:599-603. 2007
2007 Acute graft-versus-host disease after liver transplantation: Role of withdrawal of immunosuppression in therapeutic managementLiver Transplantation and Surgery.  13:157-161. 2007
2006 Radiofrequency thermal ablation of hepatocellular carcinoma before liver transplantation - A clinical and histological examinationClinical Transplantation.  20:695-705. 2006
2006 Renal cell carcinoma associated with prominent angioleiomyoma-like proliferation: Report of 5 cases and review of the literatureAmerican Journal of Surgical Pathology.  30:1372-1381. 2006
2006 Diagnostic molecular pathology: An increasingly indispensable tool for the practicing pathologistArchives of Pathology and Laboratory Medicine.  130:1339-1348. 2006
2006 Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: A significant likelihood of subsequently diagnosed adenocarcinomaAmerican Journal of Surgical Pathology.  30:1184-1188. 2006
2006 Interobserver agreement in hepatitis C grading and staging and in the Banff grading schema for acute cellular rejection: The "Hepatitis C 3" multi-institutional trial experienceArchives of Pathology and Laboratory Medicine.  130:1157-1162. 2006
2006 Liver and kidney transplantation for polycystic liver and kidney-renal function and outcomeTransplantation.  82:501-507. 2006
2006 Radio-frequency ablation of hepatocellular carcinoma before liver transplantation: A histologic and 'TUNEL' studyLiver International.  26:746-751. 2006
2006 Composite lymphocyte-rich Hodgkin lymphoma and peripheral T-cell lymphoma associated with Epstein-Barr virus: A case report and review of the literatureArchives of Pathology and Laboratory Medicine.  130:107-112. 2006
2005 Acute Graft versus host disease after liver transplantation: Patterns of lymphocyte chimerismAmerican Journal of Transplantation.  5:2968-2973. 2005
2005 Cadaveric orthotopic auxiliary split liver transplantation and kidney transplantation: An alternative for type 1 primary hyperoxaluriaTransplantation.  80:421-424. 2005
2005 Cutaneous lymphoid hyperplasia and marginal zone B-cell lymphoma following vaccinationJournal of The American Academy of Dermatology.  53:511-515. 2005
2005 Diagnostic molecular pathology, part 2: proteomics and clinical applications of molecular diagnostics in hematopathology.Baylor University Medical Center Proceedings.  18:7-12. 2005
2005 Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): Biologic outcome in advanced cancer patientsMolecular Therapy.  11:160-172. 2005
2004 Experimental infection of NOD/SCID mice reconstituted with human CD34 + cells with Epstein-Barr virusJournal of Virology.  78:13891-13900. 2004
2004 Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantationJournal of Infectious Diseases.  189:2037-2046. 2004
2003 The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantationTransplantation.  76:1583-1588. 2003
2003 Diagnostic molecular pathology: current techniques and clinical applications, part I.Baylor University Medical Center Proceedings.  16:379-383. 2003
2003 A model to predict severe HCV-related disease following liver transplantationHepatology.  38:34-41. 2003
2003 Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patientsCancer Gene Therapy.  10:341-352. 2003
2003 Liver transplant-associated graft-versus-host diseaseTransplantation.  75:118-126. 2003
2003 Predictors for nonsentinel node involvement in breast cancer patients with micrometastases in the sentinel lymph node.Baylor University Medical Center Proceedings.  16:3-6. 2003
2003 Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis CAmerican Journal of Transplantation.  3:626-630. 2003
2002 Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disordersTransplantation.  74:1090-1095. 2002
2002 Delay of hepatitis C recurrence in liver transplant recipients: Impact of mycophenolate mofetil on transplant recipients with severe acute rejection or with renal dysfunctionTransplantation Proceedings.  34:1561-1562. 2002
2002 Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetilTransplantation Proceedings.  34:1563-1564. 2002
2002 Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipientsLiver Transplantation and Surgery.  8:519-526. 2002
2001 Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type I [1] letters)New England Journal of Medicine.  345:64-66. 2001
2001 Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: Safety, feasibility and biological activityGene Therapy.  8:746-759. 2001
2001 Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type INew England Journal of Medicine.  344:270-274. 2001
2001 Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancerClinical Cancer Research.  7:691-703. 2001
2000 CD40 ligand-induced apoptosis is Fas-independent in human multiple myeloma cellsLeukemia & Lymphoma.  36:543-558. 2000
2000 Fatal graft-versus-host disease associated with solid-organ transplantationBlood.  96. 2000
2000 Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patientsLiver Transplantation and Surgery.  6:553-561. 2000
1999 In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areasJournal of Experimental Medicine.  190:1417-1425. 1999
1999 Detection of low level benzene exposure in supermarket wrappers by urinary muconic acidBiomarkers.  4:106-117. 1999
1998 Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: Is chronic rejection part of the disease process?Transplantation.  66:1300-1306. 1998
1998 Long-term outcome of patients transplanted with livers from hepatitis C- positive donorsTransplantation.  65:925-929. 1998
1998 De novo hepatitis B infection after liver transplantation: Source of disease, incidence and impactLiver Transplantation and Surgery.  4. 1998
1998 Protection by cyclosporine a against normothermic liver ischemia- reperfusion in pigsJournal of Surgical Research.  75:116-126. 1998
1997 Apoptosis induced in advanced CD8F1-murine mammary tumors by the combination of PALA, MMPR and 6AN precedes tumor regression and is preceded by ATP depletionCancer Chemotherapy and Pharmacology.  40:376-384. 1997
1995 Changing Pattern of Expression of the Epidermal Growth Factor Receptor and Transforming Growth Factor α in the Progression of Prostatic NeoplasmsClinical Cancer Research.  1:545-550. 1995
1995 The predictive value of hepatocyte glycogen content on liver allograft biopsy: Correlation with early graft functionTransplantation.  59:141-143. 1995
1995 Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVACJournal of Clinical Oncology.  13:1384-1390. 1995
1994 Molecular biologic aspects of human prostatic carcinoma.American Journal of Clinical Pathology.  102:S57-S64. 1994
1994 Molecular biologic aspects of human prostatic carcinomaAmerican Journal of Clinical Pathology.  102. 1994
1993 Fat-suppressed three-dimensional MR imaging of the breast.Radiographics.  13:247-267. 1993
1993 Heterotransplantation of human multiple myeloma cell lines in severe combined immunodeficiency (SCID) miceAnticancer Research.  13:593-597. 1993
1993 OKT3 rescue for steroid-resistant rejection in adult liver transplantationTransplantation.  55:87-91. 1993
1990 Sclerosing mediastieitis: Improved management with histoplasmosis titer and ketoconazoleAnnals of Thoracic Surgery.  50:215-221. 1990
1990 Steroid receptors in benign mastectomy tissueAmerican Journal of Clinical Pathology.  94:14-17. 1990

Book

Year Title Altmetric
2018 Genomic Applications in Pathology 2018
2014 Biopsy interpretation of the prostate: Fifth edition 2014

Chapter

Year Title Altmetric
2015 Prostate and seminal vesicles 2015
2013 Molecular pathology of urinary bladder cancer.  229-253. 2013
2011 Immunohistology of the Prostate, Bladder, Kidney, and Testis.  593-661. 2011
2010 The prostate and seminal vesicles.  1870-1913. 2010

Research Overview

  • Primary research interest and contributions have focused on the evaluation of molecular biomarkers that can serve as potential markers of early detection, prognostication and therapeutic targets in the management of urologic malignancies.
  • Education And Training

  • Barnes Hospital, Washington University School of Medicine Lauren V. Ackerman Laboratory, Postdoctoral Research 1993
  • Doctor of Medicine, University of Damascus 1985
  • Baylor University Medical Center, Residency 1992
  • Baylor University Medical Center Pathology, Residency 1992
  • Baylor University Medical Center Pathology, Residency 1991
  • Memorial Sloan-Kettering Cancer Ctr, Postdoctoral Fellowship 1994
  • Memorial Sloan-Kettering Cancer Center, Postdoctoral Fellowship 1994
  • Barnes Hospital, Wash. U. S.O.M., Postdoctoral Fellowship 1993
  • Full Name

  • Georges Netto